Related Experiment Video

Updated: Jun 3, 2026

Direct Mouse Trauma/Burn Model of Heterotopic Ossification
07:01

Direct Mouse Trauma/Burn Model of Heterotopic Ossification

Published on: August 6, 2015

Potent inhibition of heterotopic ossification by nuclear retinoic acid receptor-γ agonists

Kengo Shimono1, Wei-En Tung, Christine Macolino

  • 1Department of Orthopaedic Surgery, Thomas Jefferson University College of Medicine, Philadelphia, Pennsylvania, USA.

Nature Medicine
|April 5, 2011
PubMed

Insights

A novel nuclear retinoic acid receptor-γ (RAR-γ) agonist effectively prevented heterotopic ossification in mice. This promising treatment showed minimal side effects, offering hope for debilitating bone formation conditions.

Area of Science:

  • Biomedical research
  • Regenerative medicine
  • Skeletal biology

Background:

  • Heterotopic ossification (HO) is ectopic bone formation in soft tissues, often after trauma or surgery.
  • HO leads to debilitating consequences with no definitive cure.
  • Understanding HO mechanisms is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the potential of nuclear retinoic acid receptor-γ (RAR-γ) agonists in preventing heterotopic ossification.
  • To elucidate the underlying mechanisms by which RAR-γ agonists inhibit HO.

Main Methods:

  • Treatment of mice with an RAR-γ agonist to assess HO prevention.
  • In vitro studies using mouse mesenchymal stem cells pretreated with an RAR-γ agonist.
  • Analysis of cellular signaling pathways, including Smad phosphorylation and protein levels.
  • Evaluation in transgenic mice expressing a constitutively active form of activin receptor-like kinase-2 (ALK2).

Main Results:

  • RAR-γ agonist administration essentially prevented heterotopic ossification in mice with minimal side effects.
  • Pretreated mesenchymal stem cells lost skeletogenic potential and did not form ectopic bone.
  • RAR-γ agonist treatment reduced Smad protein phosphorylation and overall levels, impacting BMP signaling.
  • HO was blocked in transgenic mice expressing a constitutively active ALK2 mutant.

Conclusions:

  • RAR-γ agonists are potent inhibitors of heterotopic ossification in mouse models.
  • These findings suggest RAR-γ agonists may be effective for treating injury-induced and congenital HO in humans.
  • Further research into RAR-γ agonists could lead to novel therapeutic strategies for HO.

More Related Videos

Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats05:55

Tension-Free Weight-Bearing Model of Steroid-Induced Osteonecrosis of Femoral Head in Rats

Published on: September 27, 2024

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...